Cornerstone Advisors (Washington)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-140
Closed -$39K 1093
2019
Q2
$39K Buy
140
+70
+100% +$17.2K ﹤0.01% 464
2019
Q1
$16K Buy
70
+27
+63% +$5.57K ﹤0.01% 641
2018
Q4
$8K Buy
43
+18
+72% +$3.69K ﹤0.01% 685
2018
Q3
$6K Buy
25
+9
+56% +$2.19K ﹤0.01% 744
2018
Q2
$3K Buy
16
+6
+60% +$1.24K ﹤0.01% 791
2018
Q1
$2K Hold
10
﹤0.01% 822
2017
Q4
$2K Hold
10
﹤0.01% 802
2017
Q3
$2K Hold
10
﹤0.01% 801
2017
Q2
$2K Sell
10
-343
-97% -$55.7K ﹤0.01% 796
2017
Q1
$55K Hold
353
0.03% 263
2016
Q4
$41K Hold
353
0.03% 296
2016
Q3
$40K Hold
353
0.03% 289
2016
Q2
$33K Hold
353
0.03% 204
2016
Q1
$28K Hold
353
0.03% 234
2015
Q4
$26K Hold
353
0.03% 269
2015
Q3
$26K Buy
353
+343
+3,430% +$24.6K 0.02% 272
2015
Q2
$1K Hold
10
﹤0.01% 699
2015
Q1
$1K Hold
10
﹤0.01% 720
2014
Q4
$1K Hold
10
﹤0.01% 698
2014
Q3
$1K Hold
10
﹤0.01% 536
2014
Q2
$1K Hold
10
﹤0.01% 570
2014
Q1
$1K Hold
10
﹤0.01% 491
2013
Q4
$1K Buy
+10
New +$526 ﹤0.01% 307

Other funds holding IDXX

Cornerstone Advisors (Washington)'s IDXX Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 140 shares — an estimated $39K sold.

Cornerstone Advisors (Washington) first reported a position in IDXX in Q4 2013 and held it in 23 quarters. The position peaked at $55K in Q1 2017. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 140 Idexx Laboratories shares in Q3 2019, an estimated $39K.
  • Cornerstone Advisors (Washington) first reported a position in Idexx Laboratories in Q4 2013 and held it in 23 quarters.
  • Cornerstone Advisors (Washington)'s Idexx Laboratories position peaked at $55K in Q1 2017.
  • 720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.